ENTITY
Takeda Pharmaceutical

Takeda Pharmaceutical (4502 JP)

220
Analysis
Health CareJapan
Takeda Pharmaceutical Co Ltd focuses on the Research & Development, Manufacturing, Sales and Marketing and Import/Export of Pharmaceutical Drugs. The Company focuses on the following core therapeutic areas: Cardiovascular & Metabolic, Oncology, Central Nervous System, Respiratory & Immunology, General Medicine (Gastrointestinal & Genitourinary) and Vaccine.
more
Refresh
25 Nov 2018 06:35

Last Week in Event SPACE: Alpine/Alps, Renault, Takeda, Trade Me, Holcim, Toshiba, GMO

Last Week in Event SPACE ... In the sordid and ongoing war for the hearts and minds of investors in Alpine Electronics (6816 JP), ISS says take...

Logo
815 Views
Share
22 Nov 2018 07:00

2Q Earnings Is the Time for Full-Year Guidance Revisions. See Who Changed Their Numbers the Most....

At the beginning of the fiscal year, Japanese companies issue full-year guidance. Most of them will then revise those number when they announce 2Q...

Logo
472 Views
Share
19 Nov 2018 07:52

Takeda/Shire IV:  Making Drug Deals

Last Monday - 12 days after Takeda Pharmaceutical (4502 JP) released earnings, and less than a week after EC Anti-Trust Phase I ended and led to a...

Logo
957 Views
Share
08 Nov 2018 16:30

Japan: Relative Price Score Update - Overbought and Oversold Sectors & Peer Groups

RELATIVE PRICE SCORE - The Relative Price Score (RPS) was introduced in an earlier insight and is a measure of stock price performance relative to...

Logo
468 Views
Share
06 Nov 2018 14:00

Smartkarma’s Week that Was in JP/​​KR: Softbank Telecom IPO & Shinsegae's Pursuit of Amazon Fresh

Below is the list of the Japan/Korea related posts put on the Smartkarma platform during the week of Oct 29.

Logo
453 Views
Share
x